Table 1 Demographic and clinical characteristics of patients with advanced-stage lung cancer
Characteristics | All patients (N = 40) | ICIs Therapy (n = 26) | Non-ICIs Therapy (n = 14) | P value |
|---|---|---|---|---|
Age, years | 0.125 | |||
<65 | 18(45.0) | 14 | 4 | |
≥ 65 | 22(55.0) | 12 | 10 | |
Sex | 0.068 | |||
Male | 32(80.0) | 23 | 9 | |
Female | 8(20.0) | 3 | 5 | |
ECOG-PS | 0.685 | |||
0 | 16(40.0) | 11 | 5 | |
≥ 1 | 24(60.0) | 15 | 9 | |
Histopathology | 0.179 | |||
Adenocarcinoma | 24(60.0) | 13 | 11 | |
Squamous cell carcinoma | 13(32.5) | 11 | 2 | |
other | 3(7.5) | 2 | 1 | |
TNM | 0.170 | |||
Stage-III | 11(27.5) | 9 | 2 | |
Stage-IV | 29(72.5) | 17 | 12 | |
Metastasis | 0.281 | |||
Brain | 8(20.0) | 5 | 3 | |
Bone | 13(32.5) | 7 | 6 | |
Liver | 2(5.0) | 0 | 2 | |
Driver genes Positive | 19(47.5) | 10 | 9 | 0.817 |